The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Open accessAbstract
BACKGROUND AND OBJECTIVES: Levels of parathyroid hormone (PTH) and the phosphaturic hormone FGF23, a fibroblast growth factor (FGF) family member, increase early in chronic kidney disease (CKD) before the occurrence of hyperphosphatemia. This short-term 6-wk dose titration study evaluated the effect of two phosphate binders on PTH and FGF23 levels in patients with CKD stages 3 to 4. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: Patients were randomized to receive over a 6-wk period either calcium acetate (n = 19) or sevelamer hydrochloride (n = 21). RESULTS: At baseline, patients presented with elevated fractional excretion of phosphate, serum PTH, and FGF23. During treatment with both phosphate binders there was a progressive decline in serum PTH and urinary phosphate, but no change in serum calcium or serum phosphate. Significant changes were observed for FGF23 only in sevelamer-treated patients. CONCLUSIONS: This study confirms the positive effects of early prescription of phosphate binders on PTH control. Prospective and long-term studies are necessary to confirm the effects of sevelamer on serum FGF23 and the benefits of this decrease on outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Levin, A., Bakris, G. L., Molitch, M., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,513
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
(1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v72198 · Cited by 1,109
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
Slatopolsky, E., Caglar, S., Pennell, J. P., Taggart, D. D., Canterbury, J. M., Reiss, E., & Bricker, N. S. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106517 · Cited by 481
Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
Burnett, S.-A. M., Gunawardene, S. C., Bringhurst, F. R., Jüppner, H., Lee, H., & Finkelstein, J. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060507 · Cited by 455
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
Shimada, T., Yamazaki, Y., Takahashi, M., Hasegawa, H., Urakawa, I., Oshima, T., Ono, K., Kakitani, M., Tomizuka, K., Fujita, T., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00474.2004 · Cited by 360
Nakanishi, S., Kazama, J. J., Nii-Kono, T., Omori, K., Yamashita, T., Fukumoto, S., Gejyo, F., Shigematsu, T., & Fukagawa, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00184.x · Cited by 209
FGF23 is a hormone-regulating phosphate metabolism—Unique biological characteristics of FGF23
Fukumoto, S., & Yamashita, T. (2007) · Bone · doi:10.1016/j.bone.2006.12.062 · Cited by 157
FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
Titan, S., Zatz, R., Graciolli, F. G., dos Reis, L. M., Barros, R. T., Jorgetti, V., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04250510 · Cited by 154
Self-citationKoiwa, F., Kazama, J. J., Tokumoto, A., Onoda, N., Kato, H., Okada, T., Nii‐Kono, T., Fukagawa, M., & Shigematsu, T. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2005.00293.x · Cited by 147
Nagano, N., Miyata, S., Abe, M., Kobayashi, N., Wakita, S., Yamashita, T., & Wada, M. (2006) · Kidney International · doi:10.1038/sj.ki.5000020 · Cited by 143
Tomiyama, C., Higa, A., Dalboni, M. A., Cendoroglo, M. N., Draibe, S. A., Cuppari, L., Carvalho, A. B., Neto, E. M., & Canziani, M. E. F. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl291 · Cited by 134
Self-citationFGF-23 and sFRP-4 in Chronic Kidney Disease and Post-Renal Transplantation
Pande, S., Ritter, C. S., Rothstein, M., Wiesen, K., Vassiliadis, J., Kumar, R., Schiavi, S. C., Slatapolsky, E., & Brown, A. J. (2006) · Nephron Physiology · doi:10.1159/000093277 · Cited by 118
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Isakova, T., Gutiérrez, O. M., & Wolf, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.246 · Cited by 103
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism
Kobayashi, K., Imanishi, Y., Miyauchi, A., Onoda, N., Kawata, T., Tahara, H., Goto, H., Miki, T., Ishimura, E., Sugimoto, T., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02053 · Cited by 103
Vassalotti, J. A., Uribarri, J., Chen, S., Li, S., Wang, C., Collins, A. J., Calvo, M. S., Whaley‐Connell, A. T., McCullough, P. A., & Norris, K. C. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.12.018 · Cited by 73
Cited by
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Regulation and Function of the FGF23/Klotho Endocrine Pathways
Martin, A., David, V., & Quarles, L. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00002.2011 · Cited by 594
Hu, M. C., Shiizaki, K., Kuro-o, M., & Moe, O. W. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183727 · Cited by 587
Metadata
- Authors
- Oliveira, R. B., Cancela, A. L. E., Graciolli, F. G., Dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E., & Moysés, R. M. A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2010-02
- Volume
- 5
- Issue
- 2
- Pages
- 286-291
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2138484848
- Cited by
- 357
- References
- 19
- FWCI
- 21.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.